The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cronin, F. E.
Right arrow Articles by Grupp, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cronin, F. E.
Right arrow Articles by Grupp, S. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 161: 252-259.
Copyright © 1998 by The American Association of Immunologists

Role of µ Heavy Chain in B Cell Development. I. Blocked B Cell Maturation But Complete Allelic Exclusion in the Absence of Ig{alpha}/ß1

Frank E. Cronin*, Ming Jiang{dagger}, Abul K. Abbas* and Stephan A. Grupp2,{dagger}

* Immunology Research Division, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; and {dagger} Division of Pediatric Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104

There is good evidence for a signaling role played by Ig heavy chain in the developmental transition through the pre-B cell stage. We have previously described signal-capable or signal-incapable mutants of µ heavy chain in which a signaling defect is caused by failure to associate with the Ig{alpha}/ß heterodimer. To further characterize the role of Ig heavy chain-mediated signaling in vivo, as well as in B cell development and allelic exclusion, we have created transgenic mice in which the B cells express these signal-capable and signal-incapable mutant µ chains. Failure of µ to signal via Ig{alpha}/ß results in a block in B cell development in mice expressing the signal-incapable µ. A small number of B cells in these animals do escape the developmental block and are expressed in the spleen and the periphery as B220+ transgenic IgM+ cells. These cells respond to LPS by proliferating but show no response to T-independent-specific Ag. In contrast, B cells expressing the signal-capable B cell receptor show a strong signaling response to Ag-specific stimulus. There is no Ig{alpha} seen in association with signal-deficient IgM. Thus, the B cell receptor complex is not assembled, and no signal can be delivered. Despite the block in developmental signaling, allelic exclusion is complete. There is no detectable coexpression of transgenic IgM and endogenous murine IgM, nor is there rearrangement of the endogenous heavy chain genes. This suggests that differing signaling mechanisms are responsible for the developmental transition and allelic exclusion and thus allows for separate examination of these signaling mechanisms.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
B. D. Wines, H. M. Trist, R. C. Monteiro, C. van Kooten, and P. M. Hogarth
Fc Receptor {gamma} Chain Residues at the Interface of the Cytoplasmic and Transmembrane Domains Affect Association with Fc{alpha}RI, Surface Expression, and Function
J. Biol. Chem., June 18, 2004; 279(25): 26339 - 26345.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. D. Wang, J. Lopes, A. B. Cooper, M. Dang-Lawson, L. Matsuuchi, and M. R. Clark
Selection of B lymphocytes in the periphery is determined by the functional capacity of the B cell antigen receptor
PNAS, January 27, 2004; 101(4): 1027 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. I. Brown, J. Fang, K. Alcorn, R. Barr, J. M. Kim, R. Wasserman, and S. A. Grupp
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling
PNAS, December 9, 2003; 100(25): 15113 - 15118.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Kim, J. Fang, S. Rheingold, R. Aplenc, R. Wasserman, and S. A. Grupp
Cytoplasmic {micro} Heavy Chain Confers Sensitivity to Dexamethasone-induced Apoptosis in Early B-lineage Acute Lymphoblastic Leukemia
Cancer Res., August 1, 2002; 62(15): 4212 - 4216.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. P. Stephan, E. Elgavish, H. Karasuyama, H. Kubagawa, and M. D. Cooper
Analysis of VpreB Expression During B Lineage Differentiation in {lambda}5-Deficient Mice
J. Immunol., October 1, 2001; 167(7): 3734 - 3739.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Kouro, K. Nagata, S. Takaki, S. Nisitani, M. Hirano, M. I. Wahl, O. N. Witte, H. Karasuyama, and K. Takatsu
Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition
Int. Immunol., April 1, 2001; 13(4): 485 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. W. Stern, J. Fang, S. Shusterman, G. Pierson, R. Barr, B. Pawel, L. Diller, and S. A. Grupp
Angiogenesis Inhibitor TNP-470 during Bone Marrow Transplant: Safety in a Preclinical Model
Clin. Cancer Res., April 1, 2001; 7(4): 1026 - 1032.
[Abstract] [Full Text]

Home page
 JEMHome page
Y. Chang, M. J. Bosma, and G. C. Bosma
Extended Duration of DH-JH Rearrangement in Immunoglobulin Heavy Chain Transgenic Mice: Implications for Regulation of Allelic Exclusion
J. Exp. Med., April 19, 1999; 189(8): 1295 - 1305.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.